← Open Payments lookup

ROBERT DABOVAL: Open Payments

NPI 1720540297 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$685 in 34 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $358 · 2025 $685

Food & beverage: $685
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.12$217
ABBVIE INC.9$173
Janssen Pharmaceuticals, Inc5$142
Neurocrine BioSciences, Inc.3$62
Teva Pharmaceuticals USA, Inc.2$40
Takeda Pharmaceuticals U.S.A., Inc.1$21
Alkermes, Inc.1$17
Lundbeck LLC1$14

Products named: REXULTI, VRAYLAR, SPRAVATO, INGREZZA, AUSTEDO XR, TRINTELLIX, LYBALVI, ABILIFY MAINTENA.

Industry payments across TX — which companies pay providers there.